Biogen Newsroom

Argus Cuts Biogen's Price Target to $200 From $250

MT NewswiresNov 6 03:14 · Ratings

Are Investors Undervaluing Biogen (BIIB) Right Now?

Yahoo FinanceNov 5 22:40

J.P. Morgan Maintains Biogen(BIIB.US) With Hold Rating, Cuts Target Price to $210

Futu NewsNov 5 03:31 · Ratings

JP Morgan Maintains Neutral on Biogen, Lowers Price Target to $210

BenzingaNov 4 22:37 · Ratings

Biogen Analyst Ratings

BenzingaNov 4 22:36 · Ratings

Biogen Stock Touches 52-week Low at $173.01 Amid Market Challenges

InvestingNov 4 22:32

Biogen (BIIB) Loses -6.4% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner

Zacks Nov 4 21:40

Executive Reshuffles: BIIB, USB and WES

Seeking AlphaNov 3 03:54

The Boston Globe Explores How Companies Are Working to Advance Medicine and Highlight Innovation at First Annual Future Of Medicine Event

PR NewswireNov 1 21:05

A Quick Look at Today's Ratings for Biogen(BIIB.US), With a Forecast Between $190 to $302

Futu NewsNov 1 21:00 · Ratings

Biogen Partner Eisai Completes FDA Submissions for Injectable Alzheimer's Therapy

Seeking AlphaNov 1 20:16

Biogen Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Yahoo FinanceNov 1 18:18

Reported Earlier, Eisai And Submit LEQEMBI BLA For Subcutaneous Alzheimer's Treatment To FDA, Targeting Early Disease Stages

BenzingaNov 1 15:29

Roche's Antibody Against Alzheimer's Looks the Best Yet -- Barrons.com

Barron'sNov 1 05:31

Express News | Barclays lowered Boqian's target price from $190.00 to $180.00.

BreakingsNov 1 02:17

Biogen Price Target Cut to $180.00/Share From $190.00 by Barclays

Dow JonesNov 1 02:11 · Ratings

Biogen Analysts Slash Their Forecasts After Q3 Results

BenzingaNov 1 01:28

Biogen Is Maintained at Buy by TD Cowen

Dow JonesNov 1 01:07 · Ratings

TD Cowen Maintains Buy on Biogen, Lowers Price Target to $275

BenzingaNov 1 01:04 · Ratings

This Kraft Heinz Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

BenzingaNov 1 00:16